These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.
    Author: Martinek M, Aichinger J, Nesser HJ, Ziegler PD, Purerfellner H.
    Journal: J Cardiovasc Electrophysiol; 2007 Aug; 18(8):818-23. PubMed ID: 17573835.
    Abstract:
    INTRODUCTION: Long-term outcome of radiofrequency ablation (RFA) for atrial fibrillation (AF) is difficult to assess. This study sought to evaluate various aspects of very long-term follow-up (FU) by the properties of an implantable device. METHODS: Fourteen patients with an implanted pacemaker device (Medtronic AT500) were selected for RFA, due to drug-refractory and highly symptomatic AF despite antibradycardic pacing. RESULTS: With a mean FU of 41.4 +/- 15.1 months, we could achieve continuous monitoring for more than 400,000 hours after RFA. Based on symptomatic episodes, simulated 24-hour, 48-hour, or 7-day Holter, 57% to 71% of the patients were classified as RFA responders. With permanent FU provided by the implanted device, 43% of the patients exhibited a positive treatment effect and only 21% had no tachyarrhythmic episode at all in long-term FU. With a mean of 1.7 +/- 0.7 RFA per subject, atrial tachyarrhythmia burden (ATB) was significantly reduced from a median of 3.6 to 0.3 hours per day (P < 0.001). Two out of 14 patients developed AF recurrences after a tachyarrhythmia-free period of more than 12 months. CONCLUSION: Continuous monitoring provided by an implantable device is able to detect significantly more AF episodes than routine FU. ATB is decreased significantly by (repeated) RFA over a very long-term FU. AF may reoccur very late after long-lasting (>1 year) episode-free intervals. A subgroup of patients with drug-aggravated bradycardia in brady-tachy syndrome might be considered for PV isolation rather than pacemaker implantation.
    [Abstract] [Full Text] [Related] [New Search]